Another great submission for the Belgian Society of Medical Oncology #bsmoxmas Jumper Xmas Campaign by the oncology team from UZA Hans Prenen Timon Vandamme Laure-Anne Teuwen Annelies Verbiest #SevilayAltintas and others
🇧🇪 ⭐️🧑‍🎄🎄📸 StichtingtegenKanker

A panel of GI oncologists discuss the emerging data likely to impact clinical practice

Watch the recorded discussion here 👉cor2ed.com/gi-connect/pro…

Organised in partnership with eChinaHealth and GI CONNECT members Dominik Paul Modest Hans Prenen
#MedEd

🔥 Live vanuit Madrid met dagelijkse #ESMO2023 updates! 🇪🇸 Volg ons en blokkeer alvast 8/11 voor onze exclusieve Post-ESMO avond. Dé kans om dieper in de hoogtepunten te duiken en te netwerken.
👉medimix.be/post-esmo-2023…

#MediMix #PostESMO2023 #ESMO2023 #oncologie #Oncology

MTAP loss in #BiliaryCancer in up to 20% of patients. Matched treatment study currently ongoing at our institution UZA (PI Hans Prenen) #ESMO2023

Have not read the paper yet, but am sure the RadOncs will react soon (as they did with Prospect in rectal) :)

Thanks Willem Lybaert for taking pictures on all important oncology meetings :)

To select the most notable data from the oral abstract session on #GIcancer @ #ASCO23 MediMix sought the expertise of Prof. Dr Hans Prenen Hans Prenen, a digestive oncologist at UZA
➡️ Video at bit.ly/3oOsNwU

🚨🚨🚨 PROSPECT Trial has landed!

Congratulations to all investigators, Alliance for Clinical Trials in Oncology, for this important trial!

This study is important, will shape, and SHOULD alter practice for OPERATIVELY managed patients with favorable risk LA- rectal cancer.

nejm.org/doi/full/10.10…

The accompanying paper in Journal of Clinical Oncology is very important, as both regimens have distinct toxicity profiles.
Patient-Reported Outcomes (PROs) During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)
ascopubs.org/doi/full/10.12…
#ASCO23

Late breaking at #ASCO23 : In the PROSPECT trial comparing preoperative chemoradiotherapy and FOLFOX in patients with rectal cancer undergoing sphincter-sparing surgery, 5-year disease-free survival was 80.8% with FOLFOX and 78.6% with chemoradiotherapy. nej.md/3WMEmkS

🚨 #OncologyNursing podcast🚨

'Management of Skin Toxicity with Multikinase Inhibitors'

Listen to Beth Wittmer #RN & Hans Prenen from GI CONNECT discuss this topic in this 20-min #MedEd podcast

👉ow.ly/YlL350Omp6e

#CRC SM #CRC #Nurse

A reminder that Elsevier made $10.5 BILLION in 2022 from selling your academic journals and articles behind paywalls, and make more profit than Amazon, Google, and Apple every year…

And paid the academics who wrote the articles $0
And paid the reviewers of the articles $0

'Nergens zijn automobilisten zo agressief als in België.'
Zeno (32) doorkruiste bijna heel Europa met de fiets: “Ik kan eerlijk zeggen: in België hebben we een probleem”

hln.be/binnenland/zen…

Thanks for sharing, hope you like the figures! Laure-Anne Teuwen

'Ik heb uitgezaaide longkanker, zo goed als ongeneesbaar. Ik heb verschillende keren geprobeerd om te stoppen met roken, maar het lukt me niet.'

Waarom is het zo moeilijk om te stoppen met roken? Bekijk hier de #terzaketv reportage van stein falk: vrtnws.be/p.RqkPvZbXRp6

Country and gender (non-)diversity in oncology clinical trials at #ASCO22

A study by #GLOWgroup

Poster 432P @ #ESMOAsia22

AmyGDavies Joanna Young Maite Bourlon Hans Prenen Prof. Eva Segelov OncoAlert

🚨Can we drug the 'undruggable'? YES.

This is the main home message from Hans Prenen at the Belgian Society of Medical Oncology Belgian Symposium on the Integration of Molecular Biology Advances into Oncology Clinical Practice

#oncology #genomicmedicine #immunotherapy OncoAlert

GI CONNECT members Dr Renata d'Alpino and Prof. Hans Prenen discuss the increasing incidence of early-onset colorectal cancer. Watch the full video and download the summary slides @ cor2ed.com/gi-connect/pro… Renata D'Alpino Hans Prenen #oncology #MedEd

Geen idee wie dit heeft gemaakt maar bravo! #terzaketv

Honoured to be among the happy few selected as Senior Clinical Investigator by FWO, allowing me to bring a novel biosensor for the detection of circulating tumoral DNA to #neuroendocrinecancer patient care! UZA UAntwerpen #letstalkaboutnets